Interference of virginiamycin M with the initiation and the elongation of peptide chains in cell-free systems.
D000409:Alanine / Q000378:metabolism; D001426:Bacterial Proteins / Q000096:biosynthesis*; D002250:Carbon Radioisotopes; D002474:Cell-Free System; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D004926:Escherichia coli / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D046911:Macromolecular Substances; D008715:Methionine; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects*; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects*; D011485:Protein Binding; D014176:Protein Biosynthesis / Q000187:drug effects*; D011691:Puromycin; D012333:RNA, Messenger / Q000378:metabolism; D012343:RNA, Transfer / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D012270:Ribosomes / Q000187:drug effects / Q000378:metabolism; D014316:Tritium; D014769:Virginiamycin / Q000494:pharmacology*
D001426:Bacterial Proteins; D002250:Carbon Radioisotopes; D046911:Macromolecular Substances; D012333:RNA, Messenger; D012367:RNA, Viral; D014316:Tritium; D014769:Virginiamycin; D011691:Puromycin; D012343:RNA, Transfer; D008715:Methionine; D000409:Alanine